comparemela.com

Latest Breaking News On - Lisa walters hoffert - Page 3 : comparemela.com

Short Interest in Flux Power Holdings, Inc. (NASDAQ:FLUX) Increases By 5.5%

Flux Power Holdings, Inc. (NASDAQ:FLUX – Get Free Report) was the recipient of a large growth in short interest during the month of October. As of October 15th, there was short interest totalling 299,700 shares, a growth of 5.5% from the September 30th total of 284,200 shares. Based on an average daily volume of 48,700 […]

United-states
America
Lisa-walters-hoffert
Michael-johnson
Flux-power-inc
Crown-advisors-management-inc
Securities-exchange-commission
Blackrock-inc
Toroso-investments
Nasdaq
Formidable-asset-management
Flux-power-holdings-inc

Flux Power (NASDAQ:FLUX) Shares Up 1.1%

Flux Power Holdings, Inc. (NASDAQ:FLUX – Get Free Report)’s share price shot up 1.1% during trading on Monday . The company traded as high as $3.69 and last traded at $3.58. 10,409 shares were traded during mid-day trading, a decline of 81% from the average session volume of 56,122 shares. The stock had previously closed […]

United-states
America
Michael-johnson
Lisa-walters-hoffert
Toroso-investments
Flux-power-inc
Blackrock-inc
Securities-exchange-commission
Nasdaq
B-riley-wealth-advisors-inc
Geode-capital-management
Flux-power-holdings-inc

Flux Power Holdings, Inc. (NASDAQ:FLUX) Director Sells $26,232.68 in Stock

Flux Power Holdings, Inc. (NASDAQ:FLUX – Get Free Report) Director Lisa Walters-Hoffert sold 6,761 shares of Flux Power stock in a transaction dated Monday, September 25th. The stock was sold at an average price of $3.88, for a total transaction of $26,232.68. Following the transaction, the director now owns 15,084 shares of the company’s stock, […]

United-states
America
Lisa-walters-hoffert
Formidable-asset-management
Flux-power-holdings-inc
Flux-power-company-profile
Nasdaq
Millennium-management
Crown-advisors-management-inc
Toroso-investments
Securities-exchange-commission

Daré Bioscience, Inc. (NASDAQ:DARE) Q2 2023 Earnings Call Transcript

Daré Bioscience, Inc. (NASDAQ:DARE) Q2 2023 Earnings Call Transcript August 10, 2023 Daré Bioscience, Inc. reports earnings inline with expectations. Reported EPS is $-0.1 EPS, expectations were $-0.1. Operator: Welcome to the conference hosted by Daré Bioscience to review the Company’s Financial Results for the Quarter Ended June 30, 2023, and to provide a General […]

United-states
Lisa-walters-hoffert
National-cancer-institute-on-unsplash
Clinical-trials-network
National-cancer-institute
Sildenafil-cream
Contraceptive-clinical-trials-network
Ovaprene-phase
Sildenafil-cream-phase
Annual-report
John-fair
Daré-bioscience

vimarsana © 2020. All Rights Reserved.